Advertisement
Organisation › Details
Repertoire Genesis Inc. (JP)
Eurofins Scientific (Paris:ERF) (EUFI.PA), a global scientific leader in bioanalytical testing and clinical diagnostics testing, announces the completion of the acquisition of a majority stake in Repertoire Genesis Inc. (“RG”). RG owns a unique and proprietary analytical platform, TCR/BCR (T Cell Receptor/B Cell Receptor) repertoire profiling, that enables scientists to determine the specific pathophysiological status of immune responses derived from cancer, autoimmune diseases, transplants, and infectious diseases. RG’s analytical platform is an important resource for immune-related translational research, biomarker, diagnostics and pharmaceutical development from discovery stage through to clinical trials. The acquisition of RG will further expand Eurofins’ service offering to the healthcare sector globally and strengthen its unique service portfolio and position in the global bioanalytical market. RG, with over 20 staff based in its laboratory in Osaka, is leading innovation in repertoire analysis, and is expected to establish a leading position in the Japanese bioanalytical market as a solution provider for immune-related diseases and research. Since its establishment in 2014, RG has developed and offered long-read TCR/BCR repertoire analysis based on novel bioinformatics through a wide range of R&D activity from translational research to clinical trials. RG has a master patent granted in Japan, the United States, and Europe and was the first laboratory accredited against ISO/IEC 17025 in the field of TCR/BCR repertoire analysis. *
Start | 2014-10-14 established | |
Group | Eurofins (Group) | |
Industry | TCR/BCR (T Cell Receptor/B Cell Receptor) repertoire profiling | |
Industry 2 | clinical diagnostics | |
Person | Suzuki, Ryuji (Repertoire Genesis 202205 CEO + Chairman) | |
Person 2 | Ichikawa, Masuo (Repertoire Genesis 202205 COO) | |
Region | Osaka | |
Country | Japan | |
Street | 7-7-15 Saito-asagi Saito Bioincubator 402, Ibaraki-shi | |
City | 567-0085 Osaka | |
Address record changed: 2022-06-01 | ||
Basic data | Employees | B: 11 to 50 (2022-05-31) |
* Document for »About Section«: Eurofins Scientific SE. (5/31/22). "Press Release: Eurofins Enhances Its Clinical and BioPharma Service Offering in Japan with Immune Repertoire Analysis Technology Through the Acquisition of Repertoire Genesis Inc.". Luxembourg. | ||
Record changed: 2023-07-10 |
Advertisement
More documents for Eurofins (Group)
- [1] Metrion Biosciences Ltd.. (6/9/22). "Press Release: Metrion Biosciences Appoints Dr Benedetta Montagnini as Head of European Business Development". Cambridge....
- [2] Eurofins Scientific SE. (5/31/22). "Press Release: Eurofins Enhances Its Clinical and BioPharma Service Offering in Japan with Immune Repertoire Analysis Technology Through the Acquisition of Repertoire Genesis Inc.". Luxembourg....
- [3] Berkeley Lights, Inc.. (3/9/22). "Press Release: Berkeley Lights Announces Appointment of Dr. Siddhartha Kadia as Chief Executive Officer". Emeryville, CA....
- [4] Eurofins Scientific SE. (10/14/21). "Press Release: $30m Contract for Expanded Oligo Capacity"....
- [5] Waters Corporation. (11/2/20). "Press Release: Waters Gives More Laboratories Access to Mass Spectrometry with Rapid, Easy, and Compact Radian ASAP System". Milford, MA....
- [6] Eurofins Genomics LLC. (8/6/19). "Press Release: Eurofins Genomics US Expands Gene Synthesis Capabilities with Acquisition of Blue Heron Biotech". Louisville, KY....
- [7] Eurofins Scientific. (6/25/19). "Press Release: Eurofins Expands Its Transplantation Testing Footprint with the Acquisition of Transplant Genomics Inc.". Luxembourg....
- [8] Eurofins Scientific. (6/24/19). "Press Release: Operations Returning to Normal After the Cyber Attack Announced on June 3, 2019". Luxembourg....
- [9] Eurofins Scientific. (3/5/19). "Press Release: Eurofins Delivers Solid FY 2018 Results with Revenues of EUR 3,781m (+27% yoy) and Adjusted EBITDA of EUR 720m (19.0% of revenues), in Line with Its Recently Upgraded Objectives"....
- [10] Eurofins Scientific. (10/1/18). "Press Release: Eurofins to Expand Its US Environment Testing Offering with the Acquisition of TestAmerica"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top